Systematic review on the therapeutic options for COVID-19: Clinical evidence of drug efficacy and implications

Keyphrases

• Clinical Evidence 100%
• Drug Efficacy 100%
• Therapeutic Potential 100%
• COVID-19 100%
• Retrospective Observational Study 100%
• Convalescent Plasma 100%
• Remdesivir 100%
• Hydroxychloroquine 100%
• Lopinavir 100%
• MEDLINE 50%
• Embase 50%
• Inclusion Criteria 50%
• Viral Load 50%
• Traditional Medicine 50%
• PubMed 50%
• Patients with COVID-19 50%
• Politicians 50%
• Prescribers 50%
• Novel Coronavirus 50%
• Azithromycin 50%
• Mild COVID-19 50%
• Wuhan China 50%
• Lung Inflammation 50%
• Hype 50%
• Severe COVID-19 50%
• Clinical Observational Study 50%
• Drug Clinical Trial 50%
• Evidence-based Guidance 50%
• Randomized Controlled Clinical Trial 50%
• Methylprednisolone 50%
• Tocilizumab 50%
• Coronavirus 2 50%
• China National Knowledge Infrastructure 50%
• English Language 50%
• Infrastructure Database 50%
• Chloroquine 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Clinical Trial 100%
• Observational Study 100%
• Remdesivir 100%
• Hydroxychloroquine 100%
• Lopinavir Plus Ritonavir 100%
• Dexamethasone 100%
• Coronavirinae 50%
• Controlled Clinical Trial 50%
• Azithromycin 50%
• SARS Coronavirus 50%
• Tocilizumab 50%
• Chloroquine 50%
• Pneumonia 50%
• Methylprednisolone 50%